Growth hormone deficiency in adults: A review

American Journal of the Medical Sciences

Volumn 311, Issue 4, 1996, Pages 153-166

  Meling, Torstein R ^a,b   Nylen, Eric S ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b NONE   (Norway)

Author keywords

Growth hormone deficiency; Hormone therapy

Indexed keywords

RECOMBINANT GROWTH HORMONE;

ANKLE EDEMA; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG EFFECT; FLUID RETENTION; GROWTH HORMONE DEFICIENCY; GROWTH STIMULATION; HEART ATRIUM FIBRILLATION; HORMONE SUBSTITUTION; HUMAN; HYPERLIPOPROTEINEMIA; HYPERTENSION; REVIEW;

EID: 0029923575     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-199604000-00001     Document Type: Review

References (124)

1. Raben MS. Treatment of pituitary dwarf with human growth hormone. J Clin Endocrinol. 1958;18:901-3.
2. Goeddel DV, Heyneker HL, Hozumi T, et al. Direct expression in Escherichia coli of a DNA sequence coding for human growth hormone. Nature. 1979;281:544-8.
3. Leung DW, Spencer SA, Cachianes G, et al. Growth hormone receptor and serum binding protein: Purification, cloning and expression. Nature. 1987;330:537-43.
4. Whitehead HM, Aiken B, Lewis S, Sheridan B, Hadden DR. Physiological growth hormone secretion in adult growth hormone deficiency: Comparison with normal controls. Clin Endocrinol. 1991;34:371-6.
5. Cuneo RC, Salomon F, McGauley GA, Sonksen PH. The growth hormone deficiency syndrome in adults. Clin Endocrinol. 1992;37:387-97.
6. Salomon F, Cuneo RC, Hesp R, Sonksen PH. The effect of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med. 1989;321:1797-803.
7. Cuneo RC, Salomon F, Wiles CM, Hesp R, Sonksen PH. Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength. J Appl Physiol. 1991;70: 688-94.
8. Cuneo RC, Salomon F, Wiles CM, Hesp R, Sonksen PH. Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance. J Appl Physiol. 1991;70: 695-700.
9. Cuneo RC, Salomon F, Wilmhurst P, et al. Cardiovascular effects of growth hormone treatment in growth-hormone-deficient adults: Stimulation of the renin aldosterone system. Clin Sci. 1991;81:587-92.
10. Cuneo RC, Salomon F, Wiles CM, et al. Histology of skeletal muscle in adults with GH deficiency comparison with normal muscle and response to GH treatment. Horm Res. 1992;37:23-8.
11. Cuneo RC, Salomon F, Watts GF, Hesp R, Sonksen PH. Growth hormone treatment improves lipids and lipoproteins in adults with growth hormone deficiency. Metabolism. 1993;42: 1519-23.
12. McGauley GA. Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency. Acta Paediatr Scand Suppl. 1989;356:70-2.
13. McGauley GA, Cuneo RC, Salomon F, Sonksen PH. Psychological well-being before and after growth hormone treatment in adults with growth hormone deficiency. Horm Res. 1990;33:52-4.
14. Russell-Jones DL, Weissberger AJ, Bowes SB, et al. Protein metabolism in growth hormone deficiency, and effects of growth hormone replacement therapy. Acta Endocrinol. 1993: 128(suppl 2):44-7.
15. Russell-Jones DL, Weissberger AJ, Bowes SB, et al. The effects of growth hormone on protein metabolism in adult growth hormone deficient patients. Clin Endocrinol. 1993;38: 427-31.
16. Russell-Jones DL, Watts GF, Weissberger AJ, et al. The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficiency patients. Clin Endocrinol. 1994;41: 345-50.
17. Beshyah SA, Shahi M, Skinner E, Sharp P, Foale R, Johnston DG. Cardiovascular effects of growth hormone replacement therapy in hypopituitary adults. Eur J Endocrinol. 1994;130:451-8.
18. Beshyah SA, Thomas E, Kyd P, Sharp P, Fairney A, Johnston DG. The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism. Clin Endocrinol. 1994;40:383-91.
19. Binnerts A, Swart GR, Wilson JHP, et al. The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as oil body composition. Clin Endocrinol. 1992;37:79-87.
20. Nass R, Huber RM, Klauss V, Muller OA, Schopohl J, Strasburger CJ. Effect of growth hormone replacement therapy on physical work capacity and cardiac and pulmonary function in patients with growth hormone deficiency acquired in adulthood. J Clin Endocrinol Metab. 1995;80:552-7.
21. Nass R, Strasburger CJ. Effects of growth hormone treatment on serum lipids and lipoproteins in adults with growth hormone deficiency. Eur J Endocrinol. 1994;130(suppl 2):34.
22. Bengtsson BA, Eden S, Lonn L, et al. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab. 1993;76:309-17.
23. Eden S, Wiklund O, Oscarsson J, Rosen T, Bengtsson BA. Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations. Arterioscler Thromb. 1993;13:296-301.
24. Caidahl K, Eden S, Bengtsson BA. Cardiovascular and renal effects of growth hormone. Clin Endocrinol. 1994;40:393-400.
25. Baum HBA, Biller BM, Baker KE, Klibanski A. Physiologic growth hormone (GH) replacement improves body composition and bone density in men with adult-onset GH-deficiency. 76th Annual Endocrine Society Meeting Abstract. Anaheim, CA. 1994.
26. Jorgensen JOL, Pedersen SA, Thuesen L, et al. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet. 1989;i:1221-5.
27. Jorgensen JOL, Pedersen SA, Laurberg P, Weeke J, Skakkebaek NE, Christiansen JS. Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism. Metabolism. 1989;41:728-31.
28. Christiansen JS, Jorgensen JOL, Pedersen SA, Moller J, Jorgensen J, Skakkebaek NE. Effects of growth hormone on body composition in adults. Horm Res. 1990;33(suppl 4): 61-4.
29. Jorgensen JOL, Pedersen SA, Thuesen L, et al. Long-term growth hormone treatment in growth hormone deficient adults. Acta Endocrinol. 1991;125:449-53.
30. Schlemmer A, Johansen JS, Pedersen SA, Jorgensen JOL, Hassager C, Christiansen C. The effect of growth hormone (GH) therapy on urinary pyridinoline cross-links in GH-deficient adults. Clin Endocrinol. 1991;35:471-6.
31. Jorgensen JOL, Moller J, Skakkebaek NE, Weeke J, Christiansen JS. Thyroid function during growth hormone therapy. Horm Res. 1992;38(suppl 1):63-7.
32. Jorgensen JOL, Thuesen L, Muller J, Ovesen P, Skakkebaek NE, Christiansen JS. Three years of growth hormone treatment in growth hormone-deficient adults: Near normalization of body composition and physical performance. Eur J Endocrinol. 1994;130:224-8.
33. O'Halloran DJ, Tsatsoulis A, Whitehouse RW, Holmes SJ, Adams JE, Shalet SM. Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. J Clin Endocrinol Metab. 1993;76:1344-8.
34. Astrom C, Pedersen SA, Lindholm J. The influence of growth hormone on sleep in adults with growth hormone deficiency. Clin Endocrinol. 1990;33:495-500.
35. Rosen T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 1990;336:285-92.
36. Bengtsson BA. The consequences of growth hormone deficiency in adults. Acta Endocrinol. 1993;1 28(suppl 2):1-5.
37. Hoffman DM, O'Sullivan AJ, Baxter RC, Ho KKY. Diagnosis of growth-hormone deficiency in adults. Lancet. 1994;343:1064-8.
38. Bates AS, Evans AJ, Jones P, Clayton RN. Assessment of GH status in adults with growth hormone deficiency using serum growth hormone, serum insulin growth factor-1, and urinary growth hormone secretion. Clin Endocrinol. 1995;42: 425-30.
39. Hoeck HC, Vestergaard P, Jacobsen PE, Laurberg P. Test of growth hormone secretion in adults: Poor reproducibility of the insulin tolerance test. Eur J Endocrinol. 1995;133:303-12.
40. Whitehead HM, Boreham C, McIlrath EM, et al. Growth hormone treatment of adults with growth hormone deficiency: Results of a 13-month placebo controlled cross-over study. Clin Endocrinol. 1992;36:45-52.
41. Whitehead HM, Gilliland JS, Alien IV, Hadden DR. Growth hormone treatment in adults with growth hormone deficiency: Effect on muscle fiber size and proportions. Acta Paediatr Scand Suppl. 1989;356:65-7.
42. Raben MS. Clinical use of human growth hormone. N Engl J Med. 1962;266:82-6.
43. The GH-deficient adult study group. GH therapy in adults with acquired GH deficiency: A double-blind, randomized, placebo controlled one year intervention trial. 77th Endocrine Society Abstracts, P2-264, p. 356, June 1995, Washington, DC.
44. Thuesen L, Christiansen JS, Sorensen KE, Jorgensen JOL, Orskov H, Henningsen P. Increased myocardial contractility following growth hormone administration in normal men. Dan Med Bull. 1988;35:193-6.
45. Shahi M, Beshyah SA, Hackett O, Sharp PS, Johnston DG, Foale RA. Myocardial dysfunction in treated adult hypopituitarism: A possible explanation for increased cardiovascular mortality. Br Heart J. 1992;67:92-6.
46. Amato G, Carella C, Fazio S, et al. Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses. J Clin Endocrinol Metab. 1993;77:1671-6.
47. Thuesen L, Jorgensen JOL, Muller JR, et al. Short and long-term cardiovascular effects of growth hormone therapy in growth hormone deficient adults. Clin Endocrinol. 1994;41:615-20.
48. Frustaci A, Perrone GA, Gentiloni N, Russo MA. Reversible dilated cardiomyopathy due to growth hormone deficiency. Am J Clin Pathol. 1992;97:503-11.
49. Cuneo R, Salomon F, Wilmshurst P, Lowy C, McGauley G, Sonksen P. Cardiac failure responding to growth hormone. Lancet 1989;i:838-9.
50. Sacca L, Cittadini A, Fazio S. Growth hormone and the heart. Endocr Rev. 1994;15:555-73.
51. Markussis V, Beshyah SA, Fisher C, Sharp P, Nicolaides AN, Johnston DG. Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet. 1992;340:1188-92.
52. Rosen T, Eden S, Larson G, Wilhelmsen L, Bengtsson BA. Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol. 1993;129:195-200.
53. Johansson JO, Landin K, Tengborn L, Rosen T, Bengtsson BA. High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults. Arterioscler Thromb. 1994;14:434-7.
54. Merimee TJ, Hollander W, Fineberg SE. Studies of hyperlipidemia in the hGH deficient state. Metabolism. 1972;21: 1053-61.
55. Berg K, Dahlen G, Frick MH. LP (a) lipoprotein and pre-beta1-lipoprotein in patients with coronary heart disease. Clin Genet. 1974;6:230-5.
56. Olivecrona K, Ericsson S, Beglund L, Angelin B. Increased concentrations of serum lipoprotein (a) in response to GH treatment. BMJ. 1993;306:1726-7.
57. Angelin B, Olivecrona H, Ericsson S, Rudling M. Growth hormone and low-density lipoproteins. Acta Endocrinol. 1993;128(suppl 2):26-8.
58. Rudling M, Norstedt G, Olivecrona H, Reihner E, Gustafsson JA, Angelin B. Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Proc Natl Acad Sci USA. 1992;89:6983-7.
59. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-606.
60. Cuneo RC, Salomon F, Wiles CM, Sonksen PH. Skeletal muscle performance in adults with growth hormone deficiency. Horm Res. 1990;33(suppl 4):55-60.
61. Christiansen JS, Gammelgaard J, Orskov H, Andersen AR, Telmer S, Parving HH. Kidney function and size in normal subjects before and during growth hormone administration for one week. Eur J Clin Invest. 1981;11:487-90.
62. Henneman PH, Forbes AP, Moldawer M, Dempsey EF, Carroll EL. Effects of human growth hormone in man. J Clin Invest. 1960;39:1223-38.
63. Rosen T, Bosaeus I, Tolli J, Lindstedt G, Bengtsson BA. Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency. Clin Endocrinol. 1993;38:63-71.
64. Ho KY, Weissbuger AJ. The antinatriuretic action of biosynthetic human growth hormone in man involves activation of the renin-angiotensin-aldosterone system. Metabolism. 1990;39:133-7.
65. Moller J, Jorgensen JOL, Moller N, Hanssen KW, Pedersen EB, Christiansen JS. Expansion of extracellular volume and suppression of atrial natriuretic peptide after growth hormone administration in normal man. J Clin Endocrinol Metab. 1991;72:768-72.
66. Salomon F, Cuneo RC, Hesp R, Morris JF, Poston L, Sonksen PH. Basal metabolic rate in adults with growth hormone deficiency and in patients with acromegaly: Relationship with lean body mass, plasma insulin level and leukocyte sodium pump activity. Clin Sci. 1992;83:325-30.
67. Moller J, Jorgensen JO, Moller N, Christiansen JS, Weeke J. Effects of growth hormone administration on fuel oxidation and thyroid function in normal man. Metabolism. 1992;41:728-31.
68. Davidson MB. Effect of growth hormone on carbohydrate and lipid metabolism. Endocr Rev. 1987;8:115-31.
69. Merimee TJ, Felig P, Marliss E, Fineberg SE, Cahill GC. Glucose and lipid homeostasis in the abscence of human growth hormone. J Clin Invest. 1971;50:579-82.
70. Salomon F, Cuneo RC, Umpleby AM, Sonksen PH. Glucose and fat metabolism in adults with growth hormone deficiency. Clin Endocrinol. 1994;41:315-22.
71. Johansson J-O, Fowelin J, Landin K, Lager I, Bengtsson B-A. Growth hormone-deficient adults are insulin resistance. Metabolism. 1995;44:1126-9.
72. Weaver JU, Thaventhiran L, Noonan K, et al. The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults. Clin Endocrinol. 1994;41:639-48.
73. Wuster C, Slenczka E, Ziegler R. Erhohte pravalenz von Osteoporose und Arteriosklerose bei konventionell substituierter Hypophysenvorderlappeninsuffizienz: Bedarf einer zusatzlichen Wachstumshormon substitution. Klin Wochenshr. 1991;69:769-73.
74. Rosen T, Hansson T, Granhed H, Szucs J, Bengtsson BA. Reduced bone mineral content in adult patients with growth hormone deficiency. Acta Endocrinol. 1993;129:201-6.
75. Bagge E, Eden S, Rosen T, Bengtsson BA. The prevalence of radiographic osteoarthritis is low in elderly patients with growth hormone deficiency. Acta Endocrinol. 1993;129:296-300.
76. Thoren M, Soop M, Degerblad M, Saaf M. Preliminary study of the effects of growth hormone substitution therapy on bone mineral density and serum osteocalcin levels in adults with growth hormone deficiency. Acta Endocrinol. 1993;128: 41-3.
77. Johansen JS, Pedersen SA, Jorgensen JOL, et al. Effects of growth hormone (GH) on plasma bone Gla-protein in GH-deficient adults. J Clin Endocrinol Metab. 1990;70:916-9.
78. Vandeweghe M, Taelman P, Kaufman JM. Short- and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clin Endocrinol. 1993;39:409-15.
79. Van der Veen EA, Netelenbos JC. Growth hormone (replacement) therapy in adults: Bone and calcium metabolism. Horm Res. 1990;33(suppl 4):65-8.
80. Degerblad M, Elgindy N, Hall K, Sjoberg HE, Thoren M. Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinol. 1992;126:387-93.
81. Degerblad M, Bengtsson BA, Bremnert M, et al. Reduced bone mineral density in adults with growth hormone (GH) deficiency: Increased bone turnover during 12 months of GH substitution therapy. Eur J Endocrinol. 1995;133:180-8.
82. Tanner JM, Hughes PCR, Whitehouse RH. Comparative rapidity of response of height, limb muscle and limb fat to treatment with human growth hormone in patients with and without growth hormone deficiency. Acta Endocrinol. 1977;84: 681-96.
83. Rutherford OM, Jones DA, Round JM, Preece MA. Changes in skeletal muscle after discontinuation of growth hormone treatment in young adults with hypopituitarism. Acta Paediatr Scand Suppl. 1989;356:61-3.
84. Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Bjorntorp P, Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death. 13 year follow up of participants in the study of men born in 1913. BMJ. 1984;288:1401-4.
85. De Boer H, Blok G-J, van der veen EA. Clinical aspects of growth hormone deficiency in adults. Endocr Rev. 1995;16: 63-86.
86. Jorgensen JOL, Moller J, Alberti KG, et al. Marked effects of sustained low growth hormone (GH) levels on day-to-day fuel metabolism: Studies in GH-deficient patients and healthy untreated subjects. J Clin Endocrinol Metab. 1993;77:1589-96.
87. Black MM, Shuster S, Bottoms E. Skin collagen and thickness in acromegaly and hypopituitarism. Clin Endocrinol. 1972;1:259-63.
88. Rudman D, Feller AG, Nagraj HS, et al. Effects of human growth hormone in men over 60 years old. N Engl J Med. 1990;323:1-6.
89. Hasan W, Bouloux PMG, Cowen T, Elliot E, Barnett PS. Growth hormone treatment: Effects on sudomotor innervation. 77th Endocrine Society Abstracts, P2-280, p.360, June, 1995, Washington, D.C.
90. Lobie PE, Breipohl W, Lincoln DT, Garcia-Aragon J, Waters MJ. Localization of the growth hormone receptor/ binding protein in skin. J Endocrinol. 1990;126:467-72.
91. Kiess W, Doerr H, Eisl E, Butenandt O, Belohradsky BH. Lymphocyte subsets and natural-killer activity in growth hormone deficiency. N Engl J Med. 1986;314:321.
92. Crist DM, Peake GT, Mackinnon LT, Sibbitt WL, Kraner JC. Exogenous growth hormone treatment alters body composition and increases natural killer cell activity in women with impaired endogenous growth hormone secretion. Metabolism. 1987;36:1115-7.
93. Nagy E, Berczi I, Friesen HG. Regulation of immunity in rats by lactogenic and growth hormones. Acta Endocrinol. 1983;102:351-7.
94. Casanova S, Repellin AM, Schimpff RM. Production of interleukin-1 alpha and interleukin-2 by mononuclear cells from children with growth delay in relation to degree of growth hormone deficiency: Effects of substitutive treatment. Horm Res. 1990;34:209-14.
95. Dean HJ, McTaggart TL, Fish DG, Friesen HG. The educational, vocational, and marital status of growth hormone-deficient adults treated with growth hormone during childhood. Am J Child Dis. 1985;139:1105-10.
96. Bjork S, Jonsson B, Westphal O, Levin JE. Quality of life of adults with growth hormone deficiency: A controlled study. Acta Paediatr Scand Suppl. 1989;356:55-9.
97. Hunt SM, McKenna SP, Doward LC. Preliminary report on the development of a disease-specific instrument for assessing quality of life of adults with growth hormone deficiency. Acta Endocrinol. 1993;128:37-40.
98. Rosen T, Wiren L, Wilhelmsen L, Wiklund I, Bengtsson BA. Decreased psychological well-being in adult patients with growth hormone deficiency. Clin Endocrinol. 1994;40:111-6.
99. Almquist O, Thoren M, Saaf M, Eriksson O. Effects of growth hormone substitution on mental performance in adults with growth hormone deficiency: A pilot study. Psychoneuroendocrinol. 1986;11:347-52.
100. Johansson JO, Larson G, Andersson M, et al. Treatment of growth hormone deficient adults with recombinant growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters. Neuroendocrinology. 1995;61:57-66.
101. Mendelson WB, Slater S, Gold P, Gillin JC. The effect of growth hormone administration on human sleep: A dose-response study. Biol Psychiatry. 1980;15:613-6.
102. Astrom C, Christensen L, Gjerris F, Trojaborg W. Sleep in acromegaly before and after treatment with adenectomy. Neuroendocrinology. 1992;53:328-31.
103. Astrom C, Lindholm J. Growth hormone-deficient young adults have decreased deep sleep. Neuroendocrinology. 1990;51: 82-4.
104. Pedersen SA, Welling K, Michaelsen KF, Jorgensen JOL, Christiansen JS, Skakkebaek NE. Reduced sweating in adults with GH deficiency. Lancet. 1989;ii:681-2.
105. Juul A, Skakkebaek NE. Growth hormone deficiency and hyperthermia (letter). Lancet. 1991;338:887.
106. Juul A, Behrenscheer A, Tims T, Nielsen B, Halkjaer-Kristensen, Skakkebaek NE. Impaired thermoregulation in adults with growth hormone deficiency during heat exposure and exercise. Clin Endocrinol. 1993;38:237-44.
107. Moller J, Jorgensen JOL, Leuersen T, et al. Growth hormone dose regimens in adult GH deficincy: Effects on biochemical growth markers and metabolic parameters. Clin Endocrinol. 1993;39:403-8.
108. Ross RJM. Growth hormone replacement in adults: What dose? Clin Endocrinol. 1993;39:401-2.
109. De Boer H, Blok G-J, Voerman B, de Vries P, Popp-Snijders C, van der Veen E. The optimal growth hormone replacement dose in adults, derived from bioimpedence analysis. J Clin Endocrinol Metab. 1995;80:2069-76.
110. Laursen T, Jorgensen JOL, Christiansen JS. Pharmacokinetics and metabolic effects of growth hormone injected subcutaneously in growth hormone deficient patients: Thigh versus abdomen. Clin Endocrinol. 1994;40:373-8.
111. Beshyah SA, Anyaoku V, Niththyananthan R, Sharp P, Johnston DG. The effect of subcutaneous injection site on absorption of human growth hormone: Abdomen versus thigh. Clin Endocrinol. 1991;35:409-12.
112. Jorgensen JOL, Moller N, Lauritzen T, Alberti KG, Orskov H, Christiansen JS. Evening versus morning injections of growth hormone (GH) in GH-deficient patients: Effects on 24-hour patterns of circulating hormones and metabolites. J Clin Endocrinol Metab. 1990;70:207-14.
113. Jorgensen JOL, Moller J, Moller N, Lauritzen T, Christiansen JS. Pharmacological aspects of growth hormone replacement therapy: Route, frequency and timing of administration. Horm Res. 1990;33(suppl 4):77-82.
114. Sonksen PH, Cuneo RC, Salomon F, et al. Growth hormone therapy in adults with growth hormone deficiency. Acta Paediatr Scand Suppl. 1991;379:139-46.
115. Laursen T, Jorgensen JOL, Christiansen JS. Metabolic effects of growth hormone administered subcutaneously once or twice daily to growth hormone deficient adults. Clin Endocrinol. 1994;41:337-43.
116. Moller J, Lauersen T, Mindeholm L, et al. Serum growth hormone (GH) profiles after nasally administered GH in normal subjects and GH deficient patients. Clin Endocrinol. 1994;40: 511-3.
117. Jorgensen JT, Mortensen HB, Jorgensen JOL. Patient acceptance of Nordiject: A new drug delivery system for growth hormone. DICP. 1991;25:585-8.
118. Ho KY, Weissberger AJ, Stuart MC, Day RO, Lazarus L. The pharmakokinetics, safety and endocrine effects of authentic biosynthetic human growth hormone in normal subjects. Clin Endocrinol. 1989;30:335-45.
119. Cohn L, Feller AG, Draper MW, Rudman IW, Rudman D. Carpal tunnel syndrome and gynecomastia during growth hormone treatment of elderly men with low circulating IGF-I concentration. Clin Endocrinol. 1993;39:417-25.
120. Alexander L, Appleton D, Hall R, Ross WM, Wilkinson H. Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol. 1980;12:71-9.
121. Bengtsson BA, Eden S, Ernest I, Oden A, Sjogren B. Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand. 1988;223:327-35.
122. Watanabe S, Tsunematsu Y, Fujimoto J, Komiyama A. Leukemia in patients treated with growth hormone. Lancet. 1988;i:1159.
123. Stahnke N. Leukemia in growth-hormone treated patients. An update. Horm Res. 1992;38(suppl 1):56-62.
124. Hintz RL. Untoward events in patients treated with growth hormone in the USA. Horm Res. 1992;38(suppl 1):44-8.